Literature DB >> 11035862

Impact of ambulatory blood pressure monitoring on the management of hypertension in children.

J T Flynn1.   

Abstract

BACKGROUND: Ambulatory blood pressure monitoring (ABPM) is widely utilized for the evaluation and management of hypertension in adults but has not been routinely used in the care of hypertensive children.
DESIGN: To examine the potential impact that the routine use of ABPM might have on the evaluation and management of hypertension in children, we reviewed our early experience with this technique, comparing management decisions based on ABPM with those based on casual blood pressure readings.
METHODS: Twenty children (4-17 years old) underwent ABPM for either the initial evaluation of suspected hypertension or the ongoing management of known hypertension. ABPM studies were considered abnormal if over 40% of both systolic and/or diastolic blood pressure readings were above the 95th percentile for the child's age and gender.
RESULTS: Of 13 children studied for suspected hypertension, nine had abnormal ABPM studies and were treated, but four had normal results and were therefore not treated. Of seven children with known hypertension studied by ABPM to assess their blood pressure control further, three had normal results and no management changes were made, but four had abnormal studies, prompting a change in therapy or further diagnostic testing. Overall, eight out of 20 ABPM studies led to the initiation of further diagnostic evaluation or a change in planned or ongoing therapy.
CONCLUSIONS: We conclude that ABPM has the potential to become an important tool in the evaluation and management of childhood hypertension, and suggest that more widespread use of this technique in children is appropriate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035862     DOI: 10.1097/00126097-200008000-00003

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  17 in total

1.  Ambulatory blood pressure monitoring in children: imperfect yet essential.

Authors:  Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-08-25       Impact factor: 3.714

Review 2.  A diagnostic approach for the child with hypertension.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

3.  Using simplified blood pressure tables to avoid underdiagnosing childhood hypertension.

Authors:  Ajay P Sharma; Javed Mohammed; Benson Thomas; Ram N Singh; Guido Filler
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

Review 4.  Pharmacologic treatment of chronic pediatric hypertension.

Authors:  Renee F Robinson; Milap C Nahata; Donald L Batisky; John D Mahan
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 5.  Utility of ambulatory blood pressure monitoring in children and adolescents.

Authors:  John W Graves; Mohammed Mahdi Althaf
Journal:  Pediatr Nephrol       Date:  2006-07-06       Impact factor: 3.714

Review 6.  What's new in pediatric hypertension?

Authors:  J T Flynn
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

7.  Characteristics of children with primary hypertension seen at a referral center.

Authors:  Joseph T Flynn; Michael H Alderman
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

8.  Blood pressure load, proteinuria and renal function in pre-hypertensive children.

Authors:  Riccardo Lubrano; Elisabetta Travasso; Claudia Raggi; Giuliana Guido; Raffaele Masciangelo; Marco Elli
Journal:  Pediatr Nephrol       Date:  2008-12-19       Impact factor: 3.714

9.  Office blood pressure measurement alone often misclassifies treatment status in children with primary hypertension.

Authors:  Joyce P Samuel; Cynthia S Bell; Sean A Hebert; Arun Varughese; Joshua A Samuels; Jon E Tyson
Journal:  Blood Press Monit       Date:  2017-12       Impact factor: 1.444

Review 10.  Pediatric hypertension: An update on a burning problem.

Authors:  Pier Paolo Bassareo; Giuseppe Mercuro
Journal:  World J Cardiol       Date:  2014-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.